Skip to content

Member

Christine ANDERSON

ESN · Germany

Group
ESN
Country
Germany
Roll-call participation
92.9 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
99.3 %ⓘ of 575 votes where the group had a line · ESN median 93.9 %
More facts (5)
National party
AfD Alternative für Deutschland
In office
Since 16 Jul 2024
Against clear line
3 of 553 votesⓘ
Committees
AFCO (substitute), FEMM (substitute), SANT
Member id
197475
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

92.9 %

576 of 620 final votes while in office

ESN median: 90.8 % (+2.1 pts)

Chamber median: 90.6 %

With majority line ⓘ

99.3 %

571 of 575 votes where their group had a line

ESN median: 93.9 % (+5.4 pts)

Against clear line ⓘ

0.5 %

3 of 553 votes where their group had a clear line

2 opposite (for ↔ against), 0 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

14.9 %

86 of 576 votes cast

Participation 92.9 % — ESN median 90.8 %, 27 members.ⓘ
Data as a table
Participation among the 27 members of the ESN with enough votes.
FigureParticipation
Christine ANDERSON92.9 %
ESN median90.8 %
Lowest in the group65.8 %
Highest in the group97.7 %
Members27
With majority line 99.3 % — ESN median 93.9 %, 27 members.ⓘ
Data as a table
With majority line among the 27 members of the ESN with enough votes.
FigureWith majority line
Christine ANDERSON99.3 %
ESN median93.9 %
Lowest in the group64.4 %
Highest in the group99.3 %
Members27
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of ESN; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: For Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: For Majority line: For
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: Against Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 4 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within ESN

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Marc JONGEN ESNGermany99 % of 4 976 shared80 %
Irmhild BOSSDORF ESNGermany99 % of 5 312 shared80 %
Anja ARNDT ESNGermany99 % of 4 802 shared80 %
Hans NEUHOFF ESNGermany99 % of 4 109 shared80 %
Alexander SELL ESNGermany98 % of 5 150 shared80 %
Arno BAUSEMER ESNGermany98 % of 4 795 shared80 %
René AUST ESNGermany98 % of 5 079 shared80 %
Petr BYSTRON ESNGermany98 % of 4 828 shared80 %
Mary KHAN ESNGermany97 % of 5 023 shared80 %
Siegbert Frank DROESE ESNGermany97 % of 5 071 shared80 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Volker SCHNURRBUSCH changed group ESNGermany98 % of 232 shared49 %
Gerald HAUSER PatriotsAustria77 % of 5 233 shared70 %
Petra STEGER PatriotsAustria77 % of 5 398 shared70 %
Georg MAYER PatriotsAustria77 % of 4 644 shared70 %
Roman HAIDER PatriotsAustria76 % of 5 534 shared70 %
Elisabeth DIERINGER PatriotsAustria76 % of 5 516 shared70 %
Guillaume PELTIER ECRFrance76 % of 4 784 shared64 %
Ewa ZAJĄCZKOWSKA-HERNIK changed group PatriotsPoland76 % of 1 073 shared70 %
Harald VILIMSKY PatriotsAustria76 % of 5 342 shared70 %
Mieke ANDRIESE PatriotsNetherlands75 % of 2 442 shared70 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Constitutional AffairsAFCO CommitteeSubstitute29 Jan 2026now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Special Committee on the European Democracy ShieldEUDS Special committeeMember23 Jan 2025now
Delegation for relations with the United StatesD-US DelegationMember19 Sept 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute31 Mar 202512 Jan 2026
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 202530 Mar 2025
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Show all 10 seats

Dossiers

Show all 29 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

60 contributions recorded, 1 written statement; 30 on behalf of their group; 76 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield (debate) on behalf of ESNSpeech · 1 minRead
21 May 2026The Union’s preparedness for and response to health emergencies: the case of the MV Hondius and the hantavirus warning (debate) on behalf of ESNSpeech · 1 minRead
19 May 2026EU governance under pressure – institutional responses to global challenges (debate) on behalf of ESNSpeech · 2 minRead
29 Apr 2026Commission interference in democratic process and elections (topical debate) Speech · 1 minRead
29 Apr 2026Amendment of the European Electoral Act allowing Members to vote in plenary by proxy voting during pregnancy and after giving birth (A10-0123/2026 - Juan Fernando López Aguilar) (vote) on behalf of ESNSpeech · 1 minRead
29 Apr 2026The need to combat antisemitism and protect Jewish life in Europe, following the recent attacks against the Jewish community in the Netherlands and Belgium (debate) StatementRead
27 Apr 2026Order of business on behalf of ESNSpeech · 1 minRead
11 Mar 2026Child sexual abuse online: protect children, not perpetrators (topical debate) on behalf of ESNSpeech · 1 minRead
9 Mar 2026Framework Agreement on relations between the European Parliament and the European Commission (debate) on behalf of ESNSpeech · 2 minRead
11 Feb 2026Topical debate requested by a political group (S&D) (Rule 169) - State violence in Minneapolis and the rule of law in the United States (topical debate) on behalf of ESNSpeech · 1 minRead

Show all 40 recent contributions

Questions and motions, 158

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
30 Sept 2026MOTION FOR A RESOLUTION on the need for an EU strategy to counter Islamist entryism and the influence of the Muslim Brotherhood network B-10-2026-0429Motion for a resolutionwith 3 co-authors—
14 Sept 2026MOTION FOR A RESOLUTION on the recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect the EU’s external borders B-10-2026-0410Motion for a resolutionwith 2 co-authors—
4 Sept 2026Ceuta: fact-checking before the facts E-10-2026-003507Written questionNot yet answered
4 Sept 2026Regulatory perimeter of ChatGPT’s designation as a very large online search engine E-10-2026-003506Written questionNot yet answered
1 Sept 2026Scope of ChatGPT’s designation as a very large online search engine P-10-2026-003415Priority written question1 Oct 2026
31 Aug 2026DSA data-access obligations and private conversations with generative AI assistants P-10-2026-003394Priority written question1 Oct 2026
31 Jul 2026MOTION FOR A RESOLUTION on the need to combat migrant grooming gangs B-10-2026-0373Motion for a resolutionwith 80 co-authors—
27 Jul 2026Türkiye’s long arm in European classrooms: the Maarif Foundation P-10-2026-003132Priority written questionNot yet answered
23 Jul 2026The Commission’s fractured reality II: information integrity, lawful disagreement and EU competence E-10-2026-003115Written questionNot yet answered
23 Jul 2026Hybrid threats and foreign-controlled charging infrastructure E-10-2026-003112Written questionNot yet answered

Show all 158 questions and motions

Amendments tabled in committee, 43

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT3
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT9
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ644
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ648
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ538
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ536

Show all 43 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
2 October 2026

Cite as

EU Parl Watch Research (2026). “Christine ANDERSON”. Member record. memberId 197475. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197475?page=77&scope=final&vscope=all (retrieved 2 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197475. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197475?format=application%2Fld%2Bjson (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197475,
  author = {{EU Parl Watch Research}},
  title = {{Christine ANDERSON}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197475?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197475?page=77&scope=final&vscope=all},
  urldate = {2026-10-02},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197475. Official source: https://www.europarl.europa.eu/meps/en/197475. Data: EP Open Data: member record (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}